IDXX
Income statement / Annual
Last year (2023), IDEXX Laboratories, Inc.'s total revenue was $3.66 B,
an increase of 8.72% from the previous year.
In 2023, IDEXX Laboratories, Inc.'s net income was $845.04 M.
See IDEXX Laboratories, Inc.�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$3.66 B
|
$3.37 B
|
$3.22 B
|
$2.71 B
|
$2.41 B
|
$2.21 B
|
$1.97 B
|
$1.78 B
|
$1.60 B
|
$1.49 B
|
| Cost of Revenue |
$1.47 B |
$1.36 B |
$1.33 B |
$1.14 B |
$1.04 B |
$971.70 M |
$871.68 M |
$799.99 M |
$711.62 M |
$669.69 M |
| Gross Profit |
$2.19 B |
$2.00 B |
$1.89 B |
$1.57 B |
$1.37 B |
$1.24 B |
$1.10 B |
$975.44 M |
$890.27 M |
$816.12 M |
| Gross Profit Ratio |
0.6 |
0.6 |
0.59 |
0.58 |
0.57 |
0.56 |
0.56 |
0.55 |
0.56 |
0.55 |
| Research and Development
Expenses |
$190.95 M
|
$254.82 M
|
$161.01 M
|
$141.25 M
|
$133.19 M
|
$117.86 M
|
$109.18 M
|
$101.12 M
|
$99.68 M
|
$98.26 M
|
| General & Administrative
Expenses |
$335.83 M
|
$326.25 M
|
$309.66 M
|
$300.83 M
|
$261.32 M
|
$244.94 M
|
$220.88 M
|
$207.02 M
|
$182.51 M
|
$173.89 M
|
| Selling & Marketing
Expenses |
$566.07 M
|
$524.51 M
|
$486.74 M
|
$434.44 M
|
$418.19 M
|
$387.41 M
|
$354.29 M
|
$317.06 M
|
$299.96 M
|
$283.71 M
|
| Selling, General &
Administrative Expenses |
$901.89 M
|
$850.75 M
|
$796.40 M
|
$735.27 M
|
$679.51 M
|
$632.34 M
|
$575.17 M
|
$524.08 M
|
$482.47 M
|
$457.60 M
|
| Other Expenses |
$0.00 |
$2.20 M |
$1.46 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$1.09 B |
$1.11 B |
$957.40 M |
$876.52 M |
$812.70 M |
$750.21 M |
$684.35 M |
$625.20 M |
$582.15 M |
$555.86 M |
| Cost And Expenses |
$2.56 B |
$2.47 B |
$2.28 B |
$2.01 B |
$1.85 B |
$1.72 B |
$1.56 B |
$1.43 B |
$1.29 B |
$1.23 B |
| Interest Income |
$5.63 M |
$1.07 M |
$434,000.00 |
$586,000.00 |
$427,000.00 |
$1.15 M |
$5.25 M |
$3.66 M |
$2.47 M |
$1.73 M |
| Interest Expense |
$41.58 M |
$38.79 M |
$29.37 M |
$32.54 M |
$30.63 M |
$33.59 M |
$31.97 M |
$28.39 M |
$26.77 M |
$13.70 M |
| Depreciation &
Amortization |
$114.91 M
|
$111.90 M
|
$104.60 M
|
$96.00 M
|
$88.01 M
|
$83.18 M
|
$83.14 M
|
$78.22 M
|
$68.96 M
|
$58.89 M
|
| EBITDA |
$1.22 B
|
$1.01 B
|
$1.04 B
|
$793.81 M
|
$643.68 M
|
$575.66 M
|
$501.42 M
|
$431.69 M
|
$370.29 M
|
$319.81 M
|
| EBITDA Ratio |
0.33 |
0.27 |
0.29 |
0.26 |
0.23 |
0.22 |
0.21 |
0.2 |
0.19 |
0.18 |
| Operating Income Ratio
|
0.3
|
0.27
|
0.29
|
0.26
|
0.23
|
0.22
|
0.21
|
0.2
|
0.19
|
0.18
|
| Total Other
Income/Expenses Net |
-$35.95 M
|
-$38.79 M
|
-$29.37 M
|
-$32.54 M
|
-$30.63 M
|
-$33.59 M
|
-$31.97 M
|
-$28.39 M
|
-$26.77 M
|
-$13.70 M
|
| Income Before Tax |
$1.06 B |
$859.97 M |
$902.65 M |
$661.99 M |
$522.22 M |
$457.74 M |
$381.06 M |
$321.85 M |
$273.14 M |
$246.56 M |
| Income Before Tax Ratio
|
0.29
|
0.26
|
0.28
|
0.24
|
0.22
|
0.21
|
0.19
|
0.18
|
0.17
|
0.17
|
| Income Tax Expense |
$216.13 M |
$180.88 M |
$157.81 M |
$79.85 M |
$94.43 M |
$80.70 M |
$117.79 M |
$99.79 M |
$81.01 M |
$64.60 M |
| Net Income |
$845.04 M |
$679.09 M |
$744.85 M |
$581.78 M |
$427.72 M |
$377.03 M |
$263.14 M |
$222.05 M |
$192.08 M |
$181.91 M |
| Net Income Ratio |
0.23 |
0.2 |
0.23 |
0.21 |
0.18 |
0.17 |
0.13 |
0.13 |
0.12 |
0.12 |
| EPS |
10.17 |
8.12 |
8.74 |
6.82 |
4.97 |
4.34 |
3 |
2.47 |
2.07 |
1.82 |
| EPS Diluted |
10.06 |
8.03 |
8.6 |
6.71 |
4.89 |
4.26 |
2.94 |
2.44 |
2.05 |
1.79 |
| Weighted Average Shares
Out |
$83.07 M
|
$83.62 M
|
$85.20 M
|
$85.34 M
|
$86.12 M
|
$86.86 M
|
$87.77 M
|
$89.73 M
|
$92.60 M
|
$100.09 M
|
| Weighted Average Shares
Out Diluted |
$83.98 M
|
$84.60 M
|
$86.57 M
|
$86.72 M
|
$87.54 M
|
$88.47 M
|
$89.57 M
|
$90.88 M
|
$93.65 M
|
$101.50 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
